Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Dose-Optimized, Open-Label, Safety/Tolerability and Pharmacokinetic Study With Azstarys® in Children 4 and 5 Years of Age With Attention-Deficit/Hyperactivity Disorder

NCT05721235 is registered in ClinicalTrials.gov with Corium, Inc. as lead sponsor.

NCT NCT05721235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05721235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Dose-Optimized, Open-Label, Safety/Tolerability and Pharmacokinetic Study With Azstarys® in Children 4 and 5 Years of Age With Attention-Deficit/Hyperactivity Disorder
Lead sponsor
Corium, Inc.
Phase
Phase 4
Overall status
Completed
Start date
June 2, 2023
Completion date
July 31, 2025
Enrollment
123 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit/hyperactivity disorder